Venture

Venture

Cursor is nearing a funding round of at least $2 billion, with returning investors Thrive and Andreessen Horowitz expected to lead the financing at a $50 billion valuation. The deal terms are not final and may still change.

Factory's key differentiator is its ability to switch between different foundation models, such as Anthropic's Claude or Chinese AI startup DeepSeek, enhancing its coding capabilities.

IonQ's photonic entanglement milestone is significant as it allows quantum computers to communicate across physical systems, which is essential for scalable quantum networks.

At Koodos, we're building something fundamentally different. Our focus is on backing companies that genuinely improve people's lives, while helping investors access opportunities they wouldn't normally see.

In March 2026, US startups raised $19.06 billion across 630 deals, a significant decline of 64.4% year-over-year from March 2025's $53.5 billion, which was heavily influenced by OpenAI's $40 billion mega-round.

The Vanguard S&P 500 ETF offers pure market beta at an expense ratio of 0.03%, with top holdings like NVIDIA and Apple making up over 36% of the fund.

"We were considering multiple forms of capital when we started. It just felt like the opportunity is so large that venture capital gives us the opportunity to take those risks upfront and have the possibility to generate an outsized return."

Commvault focuses on data protection and recovery in the event of cyberattacks, ransomware, and system failures for both enterprise environments and cloud providers. Its clients include 3M, Sony, and Hilton.

Kevin Warsh's filing, certified by OGE officials, provides a comprehensive overview of his financial status ahead of his Senate Banking Committee confirmation hearing, scheduled for April 21, 2026.

Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.